EDITORIAL: PRWeek launches its Pharma Focus

This week sees the launch of Pharma Focus, the latest in a series of data-based news products we are rolling out in a bid to aid comms professionals in different disciplines in the planning and execution of their work.

Every month, Pharma Focus - produced in association with researcher NOP Healthcare - will focus on a particular treatment area, starting with cholesterol-lowering products that have an effect on coronary heart disease.

Going forward, we plan to cover drugs designed to treat other high-profile medical conditions, including erectile dysfunction and breast cancer.

Each chart will register a number of key factors. First, it will show the makers of those drugs what percentage of the GPs surveyed are aware of the products on the market. It will also help illustrate how GPs came to be aware of such products. In particular, it can determine to what extent GP awareness is a function of PR techniques, for example this week via articles in medical journals.

Furthermore, when the first six regime areas have been addressed, we plan to return to them six months on - to gauge how far awareness has changed, and, hopefully, to track that against specific campaigns that may have been run.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in